Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Mar 8;12:47. doi: 10.1186/s12974-015-0261-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Dai et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

The effect of central infusion of AT2-R antagonist PD123,319 on DOCA/salt-induced hypertension in female rats. Daily mean arterial pressures (MAP) (A) and heart rate (HR) (B) before and during DOCA/salt treatments in intact females with or without central infusions of PD123,319. (C,D). Average changes in MAP and HR induced by DOCA/NaCl treatment in all groups. *P < 0.05 compared to baseline, ^# P < 0.05 compared to females with central infusion of PD123,319. DOCA, deoxycorticosterone acetate; icv, intracerebroventricular.